Fiche centre
CHU de Lille
Lille — France
Essais liés5clinical trials
VilleLillelocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07570589
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| EARLY-MG — Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis | Myasthénie | À vérifier | NCT07411963 | EARLY-MG — Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis | RECRUITING |
| REAL MG PRO — Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Roz | Myasthénie | À vérifier | NCT07570589 | REAL MG PRO — Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab) | RECRUITING |
| FG-CoALS — French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis | Sclérose latérale amyotrophique | Non applicable | NCT06147843 | FG-CoALS — French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis | RECRUITING |
| DIXI Medical Microdeep® Micro- Macro Depth electrodes | Épilepsie | NA | NCT06105645 | NENUFAR — Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy | RECRUITING |
| Teriflunomide | SEP | Phase 3 | NCT02587195 | TERICIS — A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period | COMPLETED |